Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -43,847 | -11,016 | N/A | N/A |
| Depreciation Amortization | 447 | 118 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,110 | 589 | N/A | N/A |
| Other Working Capital | 2,732 | 1,139 | N/A | N/A |
| Other Operating Activity | 17,620 | -332 | 0 | 0 |
| Operating Cash Flow | $-21,938 | $-9,502 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2,251 | -443 | N/A | N/A |
| Investing Cash Flow | $-2,251 | $-443 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 1,500 | 4,000 | N/A | N/A |
| Common Stock Issued | 137 | N/A | N/A | N/A |
| Other Financing Activity | 120,056 | 11,418 | 0 | 0 |
| Financing Cash Flow | $121,693 | $15,418 | $N/A | $N/A |
| Beginning Cash Position | 7,068 | 1,595 | N/A | N/A |
| End Cash Position | 104,572 | 7,068 | N/A | N/A |
| Net Cash Flow | $97,504 | $5,473 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -21,938 | -9,502 | N/A | N/A |
| Capital Expenditure | -2,251 | -443 | N/A | N/A |
| Free Cash Flow | -24,189 | -9,945 | 0 | 0 |